Innovassynth Technologies (India) Limited
BSE: INOVSYNTH · Commodity Chemicals
Snapshot
Unlock Innovassynth Technologies (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Innovassynth Investments Ltd. operates as an investment company focused on holding equity in various body corporates. The firm is headquartered in Mumbai, India.
Business Model
The company generates value through strategic investments in other corporate entities and the management of its investment portfolio.
Management Commentary
There is currently no recent management commentary available regarding the company's strategic direction or performance.
Growth Outlook
Growth is primarily dependent on the performance and valuation of the underlying assets within the company's investment portfolio.
Key Risks
- Market Volatility. Fluctuations in the equity markets can significantly impact the valuation of the company's investment holdings.
- Concentration Risk. The company's financial health is tied to the performance of a limited number of investee companies.
- Regulatory Risk. Changes in financial regulations and investment norms in India may affect the company's operational flexibility.
- Liquidity Risk. The ability to exit investments at favourable prices may be constrained by market liquidity for the underlying assets.
Start your research today
Unlock AI insights, financials, peers and live data on Innovassynth Technologies (India) Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹3 Cr
TTM · standalone
EPS
₹0.30
TTM · standalone
RETURN ON EQUITY
5.0%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-2.6%
TTM · standalone
P/E
470.8x
Q4 FY26 · standalone
EV/EBITDA
642.5x
Q4 FY26 · standalone
DEBT TO EQUITY
0.2x
Q4 FY26 · consolidated
Peers · Commodity Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Innovassynth Technologies (India) LimitedINOVSYNTH | ₹1,312 Cr | 470.83 | 642.55 | — | 3.0% | 5.0% | -2.6% | +45.8% |
Indo Borax & Chemicals LimitedINDOBORAX | ₹1,652 Cr | 29.32 | 24.56 | 29.7% | 28.7% | 15.6% | 20.4% | +112.5% |
Citurgia Biochemicals Ltd.CITURGIA | ₹1,421 Cr | — | — | — | — | — | — | — |
The Andhra Sugars LimitedANDHRSUGAR | ₹1,349 Cr | 12.81 | 5.11 | 16.5% | 10.3% | 6.7% | 7.9% | +28.7% |
TGV SraacTGVSL | ₹1,178 Cr | 8.92 | 4.07 | — | 18.8% | 10.2% | 12.6% | -15.8% |
Amines & Plasticizers LimitedAMNPLST | ₹951 Cr | 24.66 | 14.85 | -12.4% | 10.8% | 14.0% | 19.2% | -20.9% |
As of Q4 FY26
Financials
Innovassynth Technologies (India) Limited
BSE: INOVSYNTH · Commodity Chemicals
Snapshot
Unlock Innovassynth Technologies (India) Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Innovassynth Investments Ltd. operates as an investment company focused on holding equity in various body corporates. The firm is headquartered in Mumbai, India.
Business Model
The company generates value through strategic investments in other corporate entities and the management of its investment portfolio.
Management Commentary
There is currently no recent management commentary available regarding the company's strategic direction or performance.
Growth Outlook
Growth is primarily dependent on the performance and valuation of the underlying assets within the company's investment portfolio.
Key Risks
- Market Volatility. Fluctuations in the equity markets can significantly impact the valuation of the company's investment holdings.
- Concentration Risk. The company's financial health is tied to the performance of a limited number of investee companies.
- Regulatory Risk. Changes in financial regulations and investment norms in India may affect the company's operational flexibility.
- Liquidity Risk. The ability to exit investments at favourable prices may be constrained by market liquidity for the underlying assets.
Start your research today
Unlock AI insights, financials, peers and live data on Innovassynth Technologies (India) Limited and 5,000+ companies — free.
Key Metrics
NET PROFIT
₹3 Cr
TTM · standalone
EPS
₹0.30
TTM · standalone
RETURN ON EQUITY
5.0%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
-2.6%
TTM · standalone
P/E
470.8x
Q4 FY26 · standalone
EV/EBITDA
642.5x
Q4 FY26 · standalone
DEBT TO EQUITY
0.2x
Q4 FY26 · consolidated
Peers · Commodity Chemicals
As of Q4 FY26